Home
About
Overview
Sharing Data
ORCID
Help
History (25)
Principal Investigator
Scabies
Temperance Movement
A phase 1b trial of the combination of an all-oral regimen of capecitabine and erlotinib in advanced non-small cell lung cancer in Caucasian patients.
Recent advances and emerging therapies in management of dyslipidemias.
See All 25 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Recent advances and emerging therapies in management of dyslipidemias.
Recent advances and emerging therapies in management of dyslipidemias. Trends Cardiovasc Med. 2021 10; 31(7):419-424.
View in:
PubMed
subject areas
Cardiovascular Diseases
Dyslipidemias
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypolipidemic Agents
Risk Factors
authors with profiles
Michael Davidson